There are 270 million patients with hypertension in China. The Global Burden of Disease (GBD) showed that hypertension had become the primary contributor to disability-adjusted life years in China, contributing to 24.6% of all-cause mortality (1–2). The proportion of lost life years from an early death caused by hypertension in cardiovascular and cerebrovascular disease is 64.5% and 72.8%, respectively, ranking first among all risk factors of cardiovascular and cerebrovascular diseases (2). The Healthy China Initiative (2019−2030), which was initiated by the Chinese government in 2019, has established goals for hypertension prevention and control such as regular blood pressure (BP) monitoring for adults aged 18 years or older, increasing awareness rates, and normalizing the management, treatment, and control of hypertension (Table 1). Professional public health institutions, including China CDC, attach great importance to this public health issue, and much work has been conducted in this area. This study aimed to explore the challenges and opportunities of hypertension prevention and control by reviewing the work of the China CDC in changing strategies, life-style interventions, and patient management.
Indicators (%) Baseline In 2022 In 2030 Awareness rate in residents aged 30 years or older 47 (in 2012) ≥ 55 ≥ 65 Normalized management rate in patients managed 50 (in 2015) ≥ 60 ≥ 70 Treatment rate in patients 41.1 (in 2012) Rising Rising Control rate in patients 13.8 (in 2012) Rising Rising
Table 1. Goals of hypertension prevention and control in Healthy China Initiative.